The present article briefly relates the early history and growth of the Centre for Metalloprotein Spectroscopy and Biology at UEA (University of East Anglia) under the joint directorship of A.J. Thomson and C. Greenwood, and charts the exceptional success that this centre has had in fostering bioinorganic chemistry in the U.K. and the impact that it has had internationally.
Introduction
Sitting some 60 miles south of UEA (University of East Anglia), I have watched with great admiration the growth and development of the CMSB (Centre for Metalloprotein Spectroscopy and Biology) over the past 30 years. That it has grown during this time to be internationally recognized as a world-leading centre for the study of metalloproteins is a tribute to all those involved. This year, the director of the centre, A.J. Thomson, retired, and, in the present brief article, I have tried to relate something of the story of how the Centre came into being, and to give a sense of the vision and drive that Thomson brought to it. In the space available I have not been able to do justice to the subject nor to the innumerable scientists in the U.K. and internationally who have participated in or collaborated with the CMSB and made it so successful. I hope they will forgive the many omissions.
During the 20 years from its inauguration in 1988, the CMSB has played a significant role in fostering that blend of chemistry and biology that has come to be known as inorganic biochemistry or bioinorganic chemistry. The members of the Centre, drawn from both the Schools of Biology and of Chemical Sciences, have made highly valuable and significant contributions to our understanding of a wide range of biological process involving metals, and the CMSB has fostered the careers of a large number of scientists, many of whom have moved to establish themselves in laboratories in the U.K. and around the world. For UEA, the Centre has played a very important part in the success of both the constituent departments not least in helping them to gain their excellent scores (both 5) in the last RAE (Research Assessment Exercise). The members of CMSB have published some hundreds of papers in high-quality journals and won many millions of pounds in grants in a very competitive environment. Here I have chosen to recount how the CMSB was formed and how it flourished under the directorship of A.J. Thomson and C. Greenwood and some part of its scientific endeavour that has made it a centre of excellence for inorganic biochemistry.
Background to the CSMB
It is often the case that important initiatives owe much to the serendipitous conjunction of events; for the formation of CSMB, it was the fortuitous and almost simultaneous appointment of Colin Greenwood to a lectureship in biology (1965) and Andrew Thomson first as demonstrator then to a lectureship in chemistry (1967) . These scientists came from very different backgrounds, but both had become deeply interested in that area of science that lies at the interface between chemistry, biochemistry and biophysics, and both worked on metallocomplexes, albeit of very different types. Greenwood had obtained his Ph.D. working with Q.H. Gibson at Sheffield, a centre of excellence for biochemistry, H. Krebs and G. Weber being on the staff and G. Porter was in chemistry. Gibson had designed and built one of the first stoppedflow spectrophotometers for studying rapid kinetics and had employed this to study haemoglobin, on which he had worked with Roughton in Cambridge. The subject of Greenwood's Ph.D. thesis was cytochrome c oxidase, the terminal acceptor of the mitochondrial electron-transfer chain and, in particular, the reactions of this enzyme with oxygen. These reactions proved too fast for conventional stopped-flow techniques and led to the development of the flow-flash method in which the CO derivative is dissociated in the presence of oxygen by a rapid pulse of light [1] . This pioneering technique paved the way for the elucidation of the oxygen kinetics and to the spectroscopic characterization of the intermediates in the reaction pathway. Almost all studies, up to the most recent, designed to establish links between intermediates and proton uptake and pumping have used this method.
In 1960, Gibson left Sheffield for the Johnson Foundation in Philadelphia, taking Greenwood with him. There they continued their pioneering work on cytochrome c oxidase. Greenwood shared Gibson's ability and aptitude for working with metal and machined from stainless steel the mixing block for his own stopped-flow apparatus that he eventually brought with him to UEA.
Meanwhile, in Oxford, Thomson was working for his D.Phil. under the supervision of R.J.P. Williams, a highly influential and productive inorganic chemist who had a deep interest in biology and who was central to establishing the U.K. as an important centre of bioinorganic chemistry. Thomson was working on the crystal spectra of a platinum compound called Magnus 'Green Salt'. He, like Greenwood, saw the importance of instrument development, and designed and constructed a microspectrophotometer. Given his work on platinum salts, it was natural that he then took a position as postdoctoral fellow with B. Rosenberg in Michigan, where he studied the effects of platinum salts on bacterial growth. These studies revealed the site of interaction to be DNA and from this grew the realization that platinum salts might be effective against cancerous mammalian cells. Thomson had the important insight that these salts had enantiomeric forms and it was subsequently shown that it was the cis isomer that was active. This was the starting point for the development of the highly effective and still widely used anti-cancer agents such as cisplatin. It is remarkable, and a commentary on the peculiarities of the patenting processes, that Thomson is not named on the patent of cisplatin. An informative and fascinating account of the development of cisplatin and Thomson's part in this has been published by the Wellcome Trust [2] . On appointment to UEA, Thomson, working with S.F. Mason, further developed MCD (magnetic circular dichroism) spectrophotometers capable of exploring the near-IR region of the spectrum. These prototypes and the developments that followed formed the cornerstone for much of the work that followed.
In 1968, Greenwood and Thomson met in UEA. They had different, but complementary, expertise and a commitment to innovative instrument development; they shared common interests and an ambition to do good science. Their personalities were such that they got along together very well and soon became close colleagues and friends, forging a fruitful collaboration that lasted for the next 30 years. Greenwood was interested in the metal centres, a haem and a copper atom, comprising the oxygen-reduction site in cytochrome c oxidase. These exhibit no EPR spectra even in their oxidized states. Thomson became intrigued and realized that MCD spectroscopy might provide a way to understand this system. This endeavour was aided greatly by the important technical development at this time of the split coil superconducting magnet in which a sample could be immersed in liquid helium within optical windows that remained stress-free and able to transmit circularly polarized light. This allowed spectra to be collected over a range of temperatures (1.5-300K) and field strengths and therefore magnetization curves to be determined. An investigation of the metal centres in cytochrome c oxidase and the nature of their magnetic coupling was to form a theme for their collaboration until Greenwood retired in 2000 (Greenwood sadly died in 2007).
Between 1976 and 1988, they published 69 papers both jointly and separately. They brought together skills in the techniques of MCD and EPR spectroscopy and kinetic methods to address a range of problems concerning metalloenzyme mechanism. They also sought to use spectroscopy to yield information on the structures of metal sites with emphasis on identifying ligands and ligand geometry at a time when few X-ray structures were available. They also began work on bacterial proteins, realizing their homology with mammalian systems, their great diversity and the potential for genetic manipulation. In 1985, they applied jointly to the Biochemistry and Biophysics subcommittee of Science and Engineering Research Council (SERC) and were awarded funds for largescale bacterial pilot plant fermentation facilities.
The establishment and growth of the CMSB
On the back of the success that the groups at UEA were enjoying, publishing numerous high-quality papers and pioneering the application of MCD spectroscopy to metalloproteins, the SERC established, in 1988, the CMSB, under its Molecular Recognition Initiative. This gave support to Greenwood and Thomson, and to G.R. Moore, who had recently been appointed to the School of Chemistry, to develop protein NMR, especially of paramagnetic species. Moore was well known for his work at Oxford, with R.J.P. Williams, on the NMR of cytochrome c and brought to the CMSB a powerful spectroscopic method that could be applied not only to metalloproteins but also more widely. Over the next 10 years, the SERC supported the CMSB with substantial funding in the form of rolling grants to provide infrastructure, instrumentation and enhanced facilities for protein production and structural analysis. During this time, through judicious appointment of staff to the Schools of Biology and Chemistry, some as joint appointments to both, the CMSB membership expanded by 1990 to include the research of R. James and A.G The report to the SERC written in 1999 showed that the membership of CMSB included ten academic staff, independently funded research fellows N.J. Watmough and J. Butt, later to join the permanent staff of UEA, 14 research support staff, 40 postdoctoral research assistants and 47 Ph.D. students. Between 1996 and 1999, the CMSB members published 151 papers and had a combined grant holding of over £11 million. This funding was distinct from the rolling grant supporting the centre.
In a little over 10 years, the Centre had become established and, in the mind of the scientific community, both national and international, was clearly perceived as a centre of excellence for the study of metalloproteins. From its initial concentration on kinetic studies and magneto/optical spectroscopy, the Centre now encompassed a broad range of techniques, e.g. NMR spectroscopy, X-ray structural determination and electrochemistry. Its scientific remit had similarly broadened to include the study of bacterial systems involved with the nitrogen cycle and iron storage, of protein transport systems and of bacterial defence systems. Not all of these involved metalloproteins, indicating growth from the early core interests.
Funding to the Centre continued, and N. LeBrun and M.R. Cheesman joined the Centre, but, by 2003, rolling grants ceased. However, large infrastructure grants from the Wellcome Trust allowed extensive refurbishment of laboratory space and the purchase of new X-and W-band EPR spectrometers and extension to the building that houses these instruments.
The success of the Centre depended on the quality of the scientific output from its members. It is apparent from the extensive support received from funding bodies and the papers published, both following peer review, that the science carried out in the Centre was of the highest calibre. There is no space here to review or even summarize this science. However, I will highlight just a few of what I consider the major contributions that Thomson and his co-workers made.
The interest in the initial problem of the coupling between haem a 3 and Cu B in mammalian cytochrome c oxidase led to the use of MCD spectroscopy to separate the spectral contributions of the haem group and to assign spin states to these. A series of papers followed the early studies and with the advent of the split-coil magnet, magnetization curves could be generated, linking the MCD and EPR properties of the centres. The second copper centre in cytochrome c oxidase Cu A , was also studied, and a major contribution to the debate on the nature of this site was made when it was demonstrated that this centre was identical in its MCD spectral properties with that in nitrous oxide reductase. As this latter was known to be a dimer of copper atoms (a mixed valence dimer) so by implication was the Cu A centre in cytochrome c oxidase. This important, and at the time controversial, finding was later proved correct by the determination of the X-ray structures of both mammalian and bacterial cytochrome c oxidases. The development of near-IR MCD spectrometers proved to be of great importance as it permitted the Norwich group to assign the ligand set co-ordinating a haem group from the position of the major peak in the MCD spectrum in this region. The nature of metal centres in proteins proved difficult to elucidate in the absence of crystallographic information.
However, Thomson and co-workers made enormous strides in this area and, through spectroscopic methods, were able to determine the structures of iron-sulfur clusters in three iron proteins and the structure of the copper Z site in nitrous oxide reductase, both structures being novel and unexpected.
Work on cytochrome c oxidase has continued to the present with kinetic/spectroscopic studies showing that the enzyme contains turnover species that contain protein radicals important to the mechanism, a view now widely shared. Even the initial problem of the coupling between iron and copper centres has now succumbed.
The future: the Centre for Molecular and Structural Biochemistry
With the expansion over recent years of the scientific remit of the Centre to include investigation of such topics as the E group colicins, the Centre has changed its name (but not its abbreviation) to reflect this and to signal its intentions to pursue these wider biochemical/biophysical avenues in the future. That is not to say that it will renounce its roots, as metalloprotein work will continue and remain a strength. Under the directorship of David Richardson, who has now taken over from Thomson, the micro-organisms that are involved with nitrogen metabolism will continue to be a major focus. This will involve the full range of expertise available at UEA to study the metalloproteins that lie at the heart of the cycle and their links to the biogeochemical cycle and global climate change and to preventive medicine. I am sure we all wish those at the new Centre well and are confident that it will continue the excellent scientific tradition of its predecessor.
Concluding remarks
The CMSB has been a jewel in the crown of UEA. It sprang from the enthusiasm and commitment of its founding directors. The environment was right for them. UEA was new and expanding, and Thomson and Greenwood were able to influence the way in which this growth took place. The good judgement of those in charge at UEA at the time in backing them must be acknowledged. It is difficult to see how the CMSB could have grown as it has in an established and more rigid institution. Nevertheless, it is the individual scientists on which the success depends. Thomson, as he retires, can look back on an outstanding scientific career and on an organization that he has built and which will continue to grow and to flourish.
